Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Competitors

SymbolLastChange
MRVI34.11-1.58 (-4.43%)
RHI86.06-1.93 (-2.19%)
CLVT14.08-0.58 (-3.96%)
NLSN25.54-0.11 (-0.43%)
G42.11-0.16 (-0.38%)

Company Info

Industry Miscellaneous Commercial Services
Sector Commercial Services
Employees 470
CEO Mr. Carl W. Hull
Address 10770 Wateridge Circle Suite 200, San Diego, CA 92121
Phone 1.858.546.0004
Website www.maravai.com

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The Protein Detection segment is engaged in manufacturing and selling labeling and visual detection reagents to scientific research customers for their tissue-based protein detection and characterization needs. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Statement Summary

as of 4:00 ET PM 05/23/2022
Total Assets (MRQ) 2.0 B
Total Liabilities (MRQ) 1.4 B
Shareholders’ Equity (MRQ) 654.3 M
Total Revenue (Annual) 244.3 M
Net Income (Annual) 66.9 M

Earnings And Estimates

as of 4:00 ET PM 05/23/2022

Current Qtr EPS Estimate 0.45
Current FY EPS Estimate 1.84
Long Term EPS Growth Estimate -1.50
Next Expected Earnings Date 8/9/2022

MRVI vs S&P 500

as of 05/23/2022
Relative To
S&P 500		 MRVI
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 05/23/2022
Fiscal Quarter Estimate Actual Surprise
03/2022 0.44 0.54 +23.08%
12/2021 0.38 0.45 +16.96%
09/2021 0.35 0.44 +25.09%
06/2021 0.32 0.44 +39.37%
03/2021 0.21 0.26 +25.42%
12/2020 0.11 0.24 +124.87%

Financial Strength

as of 4:00 ET PM 05/23/2022
Pre-Tax Margin 68.30
Net Margin 74.49
Operating Margin 69.00
Return On Equity 91.14
Return On Assets 13.29
Inventory Turnover (TTM) 3.12
Sales Growth (MRQ) n/a

Ratios

as of 4:00 PM ET 05/23/2022
Price/Earnings (TTM) 18.61
Price/Book (MRQ) 12.27
Price/Cash Flow (TTM) 18.51
Book Value (MRQ) 2.91
Quick Ratio (MRQ) 6.55
Current Ratio (MRQ) 7.14
Total Debt/Equity (MRQ) 1.39

Short Interest

as of 4:00 PM ET 05/24/2022
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items 0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations 0,0.00 0,0.00
Cash from
Activities 0,0.00 0,0.00
Cash from
Fin. Activities 0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 05/23/2022
Current Qtr
(06/2022)		 Next Qtr
(09/2022)
Consensus Estimate $0.45 $0.43
# of Estimates 9 9
High Estimate $0.48 $0.45
Low Estimate $0.39 $0.43
Year Ago EPS $0.44 $0.46
Year Over Year Growth Estimate 3.04% -5.31%
Current Yr
(12/2022)		 Next Yr
(12/2023)
Consensus Estimate $1.84 $1.28
# of Estimates 9 9
High Estimate $1.88 $1.53
Low Estimate $1.78 $0.96
Year Ago EPS $1.60 $1.84
Year Over Year Growth Estimate 14.80% -30.32%
Current Qtr
(06/2022)		 Next Qtr
(09/2022)		 Current Year
(12/2022)		 Next Year
(12/2023)
Consensus Estimate $0.45 $0.43 $1.84 $1.28
# of Estimates 9 9 9 9
High Estimate $0.48 $0.45 $1.88 $1.53
Low Estimate $0.39 $0.43 $1.78 $0.96
Year Ago EPS $0.44 $0.46 $1.60 $1.84
Year Over Year Growth Estimate 3.04% -5.31% 14.80% -30.32%

Insider Information Summary

as of 04/30/2022
% Insiders - 17.26%
% Remaining Total Shares - 82.74%
Current 1 Month
Net Insider Transaction 0.00 138.80 K
Shares Bought 0.00 152.10 K
Shares Sold 0.00 13.30 K

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

Recommended for You

PRESS RELEASES

The Crisis In Ukraine: Claremont McKenna College And Top Ukrainian Universities Host Symposia, Wednesday And Thursday

By PR Newswire
PRESS RELEASES

Kalera - Last Day Of Trading In Kalera AS' Shares On Euronext Growth Oslo

By GlobeNewswire
PRESS RELEASES

DZS Partners With EPS Global To Accelerate Next Generation Access Infrastructure Adoption In EMEA And Asia

By GlobeNewswire
PRESS RELEASES

Azerion Announces Executive Committee And Management Board Change 

By GlobeNewswire